Medical Devices
-
LeMaitre Set to Attend March Investor Conferences
LeMaitre Vascular (NASDAQ: LMAT) will present at key March investor conferences, updating the financial community on its innovative vascular and endovascular surgical devices. The company will highlight its R&D advancements, product pipeline, and market outlook. Discussions are expected to cover its strategic growth initiatives, financial performance, and commitment to addressing unmet clinical needs in a growing vascular device market. This engagement underscores their dedication to transparency and shareholder value.
-
Embla Medical hf: Q4 and Full Year 2025 Interim Report
Embla Medical announced its Q4 and full-year 2025 financial results, highlighting strong revenue growth driven by international product adoption. The company focused on R&D for next-generation AI-powered devices and expanded its intellectual property portfolio. Investments were made to optimize the supply chain and manufacturing for resilience. Embla Medical is optimistic about future growth, with a robust pipeline and strategic partnerships planned to advance healthcare technology.
-
ONWARD Medical Expands BCI Technology with Two More Implants for Thought-Driven Movement Restoration
ONWARD Medical has implanted its investigational ARC-BCI® Therapy in seven individuals, a significant milestone in brain-computer interface technology for spinal cord injury. This system integrates a brain implant, AI for signal decoding, and a neurostimulator to translate intended movement into functional limb motion. The therapy has received FDA Breakthrough Device Designation and is supported by substantial research grants. Further clinical trials are planned to establish broader efficacy and safety.
-
Brain-Computer Interface National Standard Approved, Synchron and Waveless Holographic Anticipate Deepening Industry Applications
China is establishing national standards for non-invasive BCI medical devices, paralleling advancements in invasive BCI clinical trials. The BCI market is rapidly growing, with applications in healthcare, cognitive enhancement, and new human-computer interaction paradigms. Companies like Neuralink and Synchron are pushing boundaries, with widespread commercialization expected within five years. Micro-vision Holography is investing heavily in BCI, aiming to integrate it with robotics and quantum computing for diverse applications. BCIs are poised for significant growth and integration across multiple sectors.
